Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perspectives From an Expert-Guided Discussion on Maximizing the Research Potential of Small Biopsy Tissue.

JCO precision oncology·2026
Same author

Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial.

JAMA oncology·2025
Same author

The College of American Pathologists Biorepository Accreditation Program: Results from the First 10 Years.

Biopreservation and biobanking·2025
Same author

Novel Postneoadjuvant Prognostic Breast Cancer Staging System.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial.

Journal of the National Cancer Institute·2024
Same journal

New progress in addressing cancer pain: Recent studies have offered revealing insights into predisposing, precipitating, and perpetuating factors as well as underlying mechanisms and potential interventions.

Cancer cytopathology·2026
Same journal

Molecular profiling of breast cancer pleural effusions using cytology specimens: Impact of sample source and cytological features on next-generation sequencing performance.

Cancer cytopathology·2026
Same journal

Accurate focal-plane selection is crucial for artificial intelligence assessment of three-dimensional urine cytology specimens for bladder cancer screening and surveillance.

Cancer cytopathology·2026
Same journal

Application of the International System for Serous Fluid Cytopathology in cerebrospinal fluid cytology: Overall survival analysis associated with diagnostic categories.

Cancer cytopathology·2026
Same journal

The performance of intraoperative peritoneal washings in detecting pancreatic ductal adenocarcinoma.

Cancer cytopathology·2026
Same journal

Supernatant: What's in a name?

Cancer cytopathology·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Biospecimen reporting for improved study quality (BRISQ).

Helen M Moore1, Andrea B Kelly, Scott D Jewell

  • 1Office of Biorepositories and Biospecimen Research, National Cancer Institute, Bethesda, Maryland, USA.

Cancer Cytopathology
|March 25, 2011
PubMed
Summary
This summary is machine-generated.

Standardizing human biospecimen handling information is crucial for reproducible research. The Biospecimen Reporting for Improved Study Quality (BRISQ) guidelines aim to improve data consistency and interpretation.

More Related Videos

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses
14:54

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Published on: September 11, 2023

Related Experiment Videos

Last Updated: Jun 3, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses
14:54

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Published on: September 11, 2023

Area of Science:

  • Biomedical research
  • Clinical diagnostics
  • Translational science

Background:

  • Human biospecimens undergo preanalytical variations affecting molecular composition and experimental reproducibility.
  • Inconsistent reporting of biospecimen handling details hinders accurate interpretation and comparison of research findings.

Framework:

  • The Biospecimen Reporting for Improved Study Quality (BRISQ) provides standardized recommendations for reporting preanalytical variables.
  • BRISQ guidelines are designed for universal application across studies utilizing human biospecimens.

Implementation:

  • BRISQ aims to enhance the quality and consistency of information reported in scientific publications and regulatory submissions.
  • Standardized reporting facilitates better evaluation, interpretation, and comparison of experimental results.

Implications:

  • Improved biospecimen data quality strengthens research integrity and reproducibility.
  • Adherence to BRISQ reassures patients and advocates that their contributions are valued and respected.